Sleep Induction Device for Immune Response Enhancement
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
COVID-19-induced insomnia impairs vaccine response and leads to impaired immune outcomes due to disrupted sleep patterns and increased neuroinflammation, causing the blood-brain barrier to become permeable, allowing inflammatory factors to enter the brain and compromising immune function.
Innovation Solution
A method to induce sleep through specific stimulation protocols, such as transcranial direct-current stimulation (tDCS) and acoustic stimulation using source-derived waveforms from EEG recordings, to enhance slow-wave sleep and improve immune response by normalizing cytokine profiles and enhancing germinal center formation for effective vaccination.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If sleep stimulation protocols (tDCS, acoustic stimulation) are applied to induce sleep, then sleep quality and immune response are improved, but device complexity and treatment protocol complexity increase
Solution Approach 1:
The patent replaces complex mechanical and procedural sleep induction methods with electrical and acoustic field stimulation. Specifically, transcranial direct current stimulation (tDCS) uses electrical fields to modulate brain activity and promote sleep, while acoustic stimulation uses sound waveforms derived from EEG recordings to induce sleep without requiring complex mechanical devices or invasive procedures.
Solution Approach 2:
The patent introduces intermediate stimuli (electrical currents for tDCS and acoustic waveforms) that mediate between the external environment and the brain's sleep-wake mechanisms. These intermediaries act as controlled interfaces that can precisely regulate sleep induction without requiring complex overall system architecture, thereby simplifying the treatment protocol while maintaining effectiveness.
2Reliability
If sleep is induced through stimulation protocols, then cytokine profiles are normalized and germinal center formation is enhanced, but treatment time and energy consumption increase
Solution Approach 1:
The patent employs periodic stimulation protocols where tDCS and acoustic stimulation are applied in repeated cycles rather than continuously. This periodic action allows the brain to respond to stimulation bursts while resting during intervals, normalizing cytokine profiles and enhancing germinal center formation over time without requiring excessively long continuous treatment sessions, thus balancing effectiveness with time efficiency.
3Object-affected harmful factors
If sleep patterns are disrupted by coronasomnia, then neuroinflammation increases and blood-brain barrier permeability increases, but conventional sleep treatments do not address the underlying immune dysfunction
Solution Approach 1:
The patent creates a multi-functional treatment system where tDCS and acoustic stimulation serve dual purposes: inducing sleep patterns and simultaneously modulating immune function. The same stimulation protocols that promote sleep also normalize cytokine profiles and enhance germinal center formation, making the treatment universally applicable to both sleep disorders and immune dysfunction without requiring separate specialized therapies.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Improves sleep quality, reduces neuroinflammation, and enhances the immune response by promoting the formation of germinal centers, leading to a more uniform and effective vaccine response, reducing the need for adaptive protocols and minimizing side effects.
Implementation Method 1
transcranial direct-current stimulation (tDCS)
Implementation Method 2
acoustic stimulation using source-derived waveforms from EEG recordings
Data Source
AI summary
A device, system, and method for facilitating a sleep cycle in a subject during a pandemic or peri COVID vaccination period, comprising determining a current awake or sleep stage of a person; automatically defining a desired sleep cycle pattern, dependent on the current awake or sleep stage of the person; generating an audio or optical stimulation pattern by an automated processor; and entraining brainwaves of the brain of the person with the stimulation pattern corresponding to the desired sleep cycle pattern, to thereby induce a sleep cycle in the person according to the sleep cycle pattern. When sleep patterns are normalized, a SARS-Cov-2 vaccination may be administered to the person.